Labcorp Files 8-K for Regulation FD Disclosure & Exhibits
Ticker: LH · Form: 8-K · Filed: Jan 16, 2024 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Laboratory Corp Of America Holdings (LH) |
| Form Type | 8-K |
| Filed Date | Jan 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, compliance, 8-K, disclosure
TL;DR
**Labcorp just filed a routine 8-K for disclosure and exhibits, showing standard compliance.**
AI Summary
Laboratory Corporation of America Holdings (Labcorp) filed an 8-K on January 16, 2024, to disclose information under Regulation FD and to include financial statements and exhibits. This filing, while routine, indicates Labcorp is actively complying with SEC disclosure requirements, which is important for investors as it signals transparency and adherence to regulatory standards. For shareholders, this means the company is maintaining good corporate governance, which can build trust and potentially support stock stability.
Why It Matters
This filing demonstrates Labcorp's ongoing commitment to transparency and regulatory compliance, which is crucial for maintaining investor confidence and a stable stock valuation.
Risk Assessment
Risk Level: low — This 8-K is a standard regulatory filing for disclosure and exhibits, indicating routine compliance rather than a specific new risk.
Analyst Insight
A smart investor would view this as a standard compliance filing, indicating no immediate red flags or catalysts for significant stock movement. It reinforces the company's adherence to regulatory requirements, which is a positive but expected aspect of corporate governance.
Key Numbers
- January 16, 2024 — Date of earliest event reported (The date the event triggering the 8-K occurred.)
- 001-11353 — Commission File Number (Labcorp's unique identifier with the SEC.)
- 13-3757370 — I.R.S. Employer Identification No. (Labcorp's tax identification number.)
- 336-229-1127 — Registrant’s telephone number (Labcorp's primary business contact number.)
- $0.10 — par value (The stated par value of Labcorp's Common Stock.)
Key Players & Entities
- LABORATORY CORPORATION OF AMERICA HOLDINGS (company) — the registrant filing the 8-K
- Labcorp (company) — common name for the registrant
- New York Stock Exchange (company) — exchange where Labcorp's common stock is registered
- Delaware (company) — state of incorporation for Labcorp
- $0.10 (dollar_amount) — par value of Labcorp's Common Stock
Forward-Looking Statements
- Labcorp will continue to file routine 8-K disclosures as required by the SEC. (LABORATORY CORPORATION OF AMERICA HOLDINGS) — high confidence, target: 2025-01-16
- The company's stock (LH) will likely remain stable in response to this routine compliance filing. (LH) — medium confidence, target: 2024-02-16
FAQ
What is the purpose of this 8-K filing by Laboratory Corporation of America Holdings?
This 8-K filing by Laboratory Corporation of America Holdings is intended to satisfy disclosure requirements under Regulation FD and to furnish Financial Statements and Exhibits, as indicated by the 'ITEM INFORMATION' sections.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 16, 2024, as stated under 'Date of earliest event reported'.
What is the trading symbol and the exchange where Laboratory Corporation of America Holdings' common stock is registered?
The trading symbol for Laboratory Corporation of America Holdings' Common Stock is 'LH', and it is registered on the New York Stock Exchange.
What is the state of incorporation for Laboratory Corporation of America Holdings?
Laboratory Corporation of America Holdings is incorporated in Delaware, as specified under 'State or other jurisdiction of Incorporation'.
What is the business address and phone number of Laboratory Corporation of America Holdings?
The business address of Laboratory Corporation of America Holdings is 358 South Main Street, Burlington, North Carolina 27215, and their telephone number is 336-229-1127.
Filing Stats: 443 words · 2 min read · ~1 pages · Grade level 11.7 · Accepted 2024-01-16 08:01:12
Key Financial Figures
- $0.10 — nge on which registered Common Stock , $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20240116.htm (8-K) — 26KB
- formpr4q23ex991earningsann.htm (EX-99.1) — 7KB
- lc2020logov2a.gif (GRAPHIC) — 5KB
- 0000920148-24-000006.txt ( ) — 165KB
- lh-20240116.xsd (EX-101.SCH) — 2KB
- lh-20240116_lab.xml (EX-101.LAB) — 24KB
- lh-20240116_pre.xml (EX-101.PRE) — 12KB
- lh-20240116_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter and full year 2023 before the market opens on Thursday, February 15, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press release dated January 1 6 , 202 4 issued by Labcorp
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS Registrant By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary January 16, 2024